Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
If a consumer completes a consultation and is medically disqualified from all treatment options, the company states they are eligible for a full refund of the membership fee
The risk is limited track record
According to FDA communications, some compounders may use salt forms of semaglutide (such as semaglutide sodium or semaglutide acetate) rather than the semaglutide base used in FDA-approved products
These take longer to digest and compound the gastric emptying delay caused by GLP-1 medications
For semaglutide, the relevant secondary patents include: Formulation patents covering the specific inactive ingredients, pH buffers, and stabilizers that keep semaglutide stable in solution (US 9,714,283, expires 2033) Method-of-use patents covering specific dosing schedules and titration protocols (US 10,195,214, expires 2032) Delivery device patents for the pen injector mechanism used in Ozempic and Wegovy (separate patent family, expires 2029-2031) Oral formulation patents for the SNAC (salcaprozate sodium) absorption enhancer used in Rybelsus tablets (US 9,931,349, expires 2032) The expiration date that matters to you depends on which formulation you care about
Open or Close There are other weight loss treatments available through our Weight Loss Treatment service to help support weight loss, if suitable for you
US$ 27.68
US$ 20.14
US$ 24.55
US$ 23.00
US$ 28.80
US$ 23.33
